Image – Interventional flashlight

DOI: 10.4244/EIJ-D-18-00797

Interventional femoral “crossover” bypass for peripheral ischaemia under cardiocirculatory support with the Impella CP heart pump

Martin Geyer1, MD; Markus Vosseler1, MD; Tommaso Gori1, MD, PhD

Figure 1. Interventional femoral “crossover” bypass under Impella CP. A) Angiography (via 6 Fr sheath) of the right femoral axis before introduction of the Impella. B) Critical limb ischaemia (right leg) under extracorporeal augmentation with the microaxial pump. C) Interventional femoral “crossover” bypass. D) & E) Doppler signal and aspect of the right leg after restoration of limb perfusion by interventional “crossover” bypass.

In recent years, cardiocirculatory support by axial flow pump (Impella®; Abiomed, Danvers, MA, USA) has become a routinely used advanced therapy for protected percutaneous coronary intervention (PCI) and cardiogenic shock. In comparison to extracorporeal life support (ECLS), where peripheral complications by cannulation are not uncommon (8-25%)1, little evidence exists on the incidence of limb ischaemia with the Impella heart pump and its therapies (3.9% in the USpella Registry vs 4.2% need for vascular surgery not further specified in the Impella-EUROSHOCK-registry)2,3, which seems to be rare due to a smaller cannula size (14 Fr in Impella CP® vs 15-17 Fr arterial cannula in ECLS).

An Impella CP® system was implanted through the right femoral artery in an 84-year-old male patient who underwent PCI under ongoing cardiogenic shock after successful cardiopulmonary resuscitation. Before implantation of the microaxial pump, angiography of the right femoral axis showed vessels of apparently sufficient diameter to accommodate the 14 Fr sheath (Figure 1A). Following coronary stenting of the right coronary artery (performed through an additional access through the left femoral artery), the patient was haemodynamically stable with a heart rate of 80 beats/minute and a blood pressure of 120/60 mmHg. After transfer to the intensive care unit (ICU), the patient developed critical limb ischaemia of the right leg distal to the cannulation site (Figure 1B). Ischaemia was confirmed by the absence of pulse and Doppler flow. An attempt to wean the patient from Impella support failed, despite ongoing maximal vasopressor therapy. In order to restore perfusion of the affected limb, the ipsilateral superficial femoral artery was cannulated in an antegrade manner with a 6 Fr sheath under sonographic guidance. A “crossover” shortcut was established by connecting the antegrade right leg sheath with the left leg sheath used for primary stenting with a male-male adapter (Figure 1C, Moving image 1). Peripheral perfusion was restored immediately and pulsatile flow in the downstream region of the leg was confirmed by sonography (Figure 1D, Figure 1E). The patient died the next day in multiorgan failure.

We show here the feasibility of an interventional approach in peripheral ischaemia under cardiocirculatory support by an axial flow pump. Since this peripheral complication may become apparent hours after implantation, a final control angiography of the cannulated limb upon discharge from the catheterisation laboratory may be important to anticipate potential ischaemic problems.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Bypass perfusion of the ischaemic right leg by an interventional “crossover”: an antegrade 6 Fr sheath (right) is connected to a contralateral arterial 6 Fr sheath (left). After flushing the sheath with saline solution, blood flow towards the ischaemic leg can be visualised.

Volume 15 Number 14
Feb 20, 2020
Volume 15 Number 14
View full issue


Key metrics

On the same subject

10.4244/EIJ-D-19-00279L Oct 18, 2019
Impella device use in high-risk PCI
Chhabra L et al
free

CLINICAL RESEARCH

10.4244/EIJ-D-16-00371 Feb 20, 2017
Pulsatile iVAC 2L circulatory support in high-risk percutaneous coronary intervention
den Uil C et al
free

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00637 Apr 6, 2018
Percutaneous biventricular cardiac assist device in cardiogenic shock and refractory cardiac arrest
Ellert J et al
free

10.4244/EIJV13I18A344 Apr 6, 2018
Mechanical circulatory support: the last resort in cardiogenic shock?
Thiele H et al
free

EXPERIMENTAL RESEARCH

10.4244/EIJ-D-18-00684 Feb 7, 2019
Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal model
Moller-Helgestad OK et al
free

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
Trending articles
337.88

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
283.98

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
150.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
103.48

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved